Beijing Foyou Pharma (601089.SH) has received the approval notice for the listing application of alamode chemical raw materials.
Fuyuan Pharmaceuticals (601089.SH) announced that the company has recently received the approval and issuance of the chemical raw material drug marketing application approval notice for Elamod from the State Food and Drug Administration. The generic name of the drug is Elamod, which is used for the treatment of active rheumatoid arthritis.
Beijing Foyou Pharma (601089.SH) announced that the company has recently received the approval letter for the marketing application of the raw material drug Elamod, issued by the National Medical Products Administration. The generic name of the drug is Elamod, which is used to treat active rheumatoid arthritis.
With the acquisition of the approval letter for Elamod raw material drug, the company will further enrich its product line and promote the company's continued, stable, and healthy development.
Related Articles
TIME INTERCON(01729) issued 296,000 shares according to the stock plan.
As of the end of February, Midea Group Co., Ltd (00300) has repurchased a total of 26.9437 million A-shares.
WANJIA GROUP (00401): Lin Quanzhi appointed as independent non-executive director
TIME INTERCON(01729) issued 296,000 shares according to the stock plan.
As of the end of February, Midea Group Co., Ltd (00300) has repurchased a total of 26.9437 million A-shares.
WANJIA GROUP (00401): Lin Quanzhi appointed as independent non-executive director
RECOMMEND
